Bulletin
Investor Alert

New York Markets Close in:

May 26, 2020, 2:08 p.m. EDT

Global Liquid Biopsy Market Size to grow with 21.54% CAGR through 2027

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

May 26, 2020 (Market Insight Reports) -- Selbyville, Delaware According to Market Study Report, Provides A Detailed Overview Of Liquid Biopsy Market With Respect To The Pivotal Drivers Influencing The Revenue Graph Of This Business Sphere. The Current Trends Of Liquid Biopsy Market In Conjunction With The Geographical Landscape, Demand Spectrum, Remuneration Scale, And Growth Graph Of This Vertical Have Also Been Included In This Report.

MARKET OUTLOOK

According to, the global liquid biopsy market Size, Share is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 21.54%.

Request a sample Report of Liquid Biopsy Market at@ https://www.marketstudyreport.com/request-a-sample/2487064/?utm_source=marketwatch.com&utm_medium=ADS

A liquid biopsy is a non-invasive test used to detect cancer at an early stage and helps in assessing the molecular characteristics of cancer. Liquid biopsy tests help researchers, physicians and surgeons determine an appropriate therapy to improve the life expectancy of cancer patients.

Factors such as the increase in the number of cancer cases among the aging populace, rise in demand for diagnostic centers, increasing number of government initiatives, rise in use of tissue/tumor-agnostic drugs and wide usage of precision medicine are all significantly contributing to the growth of the liquid biopsy market. Opportunities like technological advancements and the rise in number of cancer patients can be leveraged by the industry to reach the projected growth. The lack of skilled professionals and the dearth of reimbursements are some of the challenges faced by this market. Also, high cost of tests and a lack of consensus on SOPs, impede the growth of the market.

REGIONAL OUTLOOK

The global liquid biopsy market spans across the regions of North America, Asia-Pacific, Latin America, Europe and the Middle East & Africa.

Presently, the APAC liquid biopsy market has highest CAGR, and is the fastest-growing market in the world. There is a probability of major market vendors shifting their sales, manufacturing & distribution facilities to the Asia-Pacific in order to benefit from the attractive proposition of easily available labor, lower cost of land & material and access to a large patient base. The end-users can thus avail the vendors' solutions at extremely low prices. Thus, economic development and growing support from the government, along with a likelihood of major market vendors shifting their operating base to the region, have created new opportunities of the growth of the liquid biopsy market in the Asia-Pacific.

COMPETITIVE OUTLOOK

The companies that have been mentioned in the global liquid biopsy market report are C. R. Bard, Inc. (acquired by Becton, Dickinson and Company), Fischer Medical Technologies LLC, Cook Medical, Inc., Cardinal Health, Inc., Bio-Rad Laboratories, Inc., Planmeca Oy, Becton, Dickinson, QIAGEN N.V., I.M.S. Internazionale Medico Scientifica Srl, Ad-Tech Medical Instrument Corp., Roche Diagnostics Corporation, Cintec Medical Ltd., B. Braun Melsungen AG, Argon Medical Devices, Boston Scientific Corporation and Agilent Technologies, Inc.

Becton, Dickinson and Company (BD) is a med-tech corporation, which is involved in improving the quality of life of patients by providing innovative solutions that help develop medical research & genomics, enhance diagnostics, improve medication management, and promote infection prevention. It is a manufacturer and distributor of medical supplies, devices, laboratory equipment, and diagnostic products worldwide. BD is actively involved in the development, manufacturing & distribution of devices, diagnostic products and laboratory equipment over the globe. The company has two subsidiaries: BD Life Sciences and BD Medical. The client base of the company includes life science researchers, healthcare institutes and public & clinical laboratories. It is present in over 50 countries.

For More Details on this report@ https://www.marketstudyreport.com/reports/global-liquid-biopsy-market-2019-2027?utm_source=marketwatch.com&utm_medium=ADS

Related Report:

Global Edible Insects Market to Amass Notable Returns By 2026

Growing inclination towards protein rich diets and increasing health awareness are major factors driving the edible insects market growth. Insects have high protein content and excellent product efficiency as compared to other food groups. Commonly consumed insects are caterpillars, grasshoppers, beetles, locusts, ants and bees. Easy availability of edible insects in Zambia, Zimbabwe and Nigeria is further aiding the market expansion. Insects including mealworms, grasshoppers, termites and crickets are a rich source of phosphorous, manganese, calcium, magnesium, iron, copper and zinc.

For More Details on this report@ https://www.marketstudyreport.com/news/edible-insects-market-growth?utm_source=marketwatch.com&utm_medium=ADS

About Us

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.